Long-term effectiveness of eptinezumab in patients with migraine and prior preventive treatment failures: extension of a randomized controlled trial

BACKGROUND: Eptinezumab demonstrated efficacy in adults with migraine and prior preventive treatment failures in the placebo-controlled phase of the DELIVER clinical trial; its long-term effectiveness in this population has not yet been reported. The objective of this study was to evaluate the long-...

Descripción completa

Detalles Bibliográficos
Autores principales: Ashina, Messoud, Tepper, Stewart J., Gendolla, Astrid, Sperling, Bjørn, Ettrup, Anders, Josiassen, Mette Krog, Starling, Amaal J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10662788/
https://www.ncbi.nlm.nih.gov/pubmed/37985968
http://dx.doi.org/10.1186/s10194-023-01688-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10662788/
https://www.ncbi.nlm.nih.gov/pubmed/37985968
http://dx.doi.org/10.1186/s10194-023-01688-w

Ejemplares similares